JHM Biopharma Raises RMB100 Million to Expand Protein Drug Pipeline
Hangzhou-based protein drug developer JHM Biopharma has reportedly secured close to RMB100 million (USD14.9 million)...
Sino Biopharma’s PD-L1 Combo with Anlotinib Accepted for Review by China’s CDE
China-based Sino Biopharmaceutical Ltd (HKG: 1177) has announced that its New Drug Application (NDA) filing...
Meheco’s Genertec Partners with AstraZeneca for COVID-19 Antibody Evusheld in China
China Meheco Group Co., Ltd (SHA: 600056) announced that its subsidiary Genertec Meheco has entered...
Guangzhou’s Overseas Pharma Wins China Clinical Trial Approval for OPL-038
Guangzhou-based Overseas Pharmaceuticals, Ltd has secured clinical trial approval in China for its sustained and...
Eyougene Raises Hundreds of Millions in Series B Funding for Expansion
Eyougene Co., Ltd, a digital Contract Development and Manufacturing Organization (CDMO) based in Shanghai, has...
LePure Bio Secures Hundreds of Millions in Series C Funding for Expansion
Shanghai LePure Biotech Co., Ltd, a China-based biotechnology company, has reportedly raised “hundreds of millions”...
Shenzhen Keyto Fluid Control Secures Series C Funding for Expansion
Shenzhen Keyto Fluid Control Co., Ltd, a China-based manufacturer of precision fluid control components, has...
Xinhua Pharma’s OAB-14 Receives NMPA Approval for Phase I Alzheimer’s Study
China-based Shandong Xinhua Pharmaceutical Co., Ltd (SHE: 000756) has announced receiving approval from the National...
Cii Tech Secures Tens of Millions in Pre-Series A Funding for Mass Spectrometry
China Innovation Instrument (Cii Tech), a life sciences instrument maker based in Ningbo, has reportedly...
TechnoDerma Raises Series A+ Funding to Advance Dermatology Pipeline
TechnoDerma Medicines Inc., a Zhejiang-based developer of dermatology small molecules, has reportedly raised “tens of...
Konruns’ KC1036 Advances to Phase II Study for Lung Adenocarcinoma
Beijing-based Konruns Pharmaceutical Co., Ltd (SHA: 603590) has announced receiving approval from the National Medical...
Harbour BioMed’s HBM1020 Receives FDA Approval for US Phase I Study
Harbour BioMed (HKG: 2142), a global biotech company operating in the Netherlands, the United States,...
Porton Pharma Solutions to Invest EUR 50 Million in Slovenia Bio-Industry Park
China-based Contract Development and Manufacturing Organization (CDMO) Porton Pharma Solutions is set to establish a...
ClouDr Partners with Shaanxi Pharmaceutical Firms for Integrated Healthcare Solutions
Hangzhou Kang Ming Information Technology Co., Ltd (HKG: 9955), better known as “ClouDr,” has announced...
Syneos Health Partners with Fosun Pharma to Commercialize Serplulimab in US
US-based Syneos Health (Nasdaq: SYNH) has revealed a strategic partnership with Fosun Pharma USA Inc.,...
Sanofi’s iGlarLixi Approved in China for Type 2 Diabetes Management
French pharmaceutical major Sanofi (NASDAQ: SNY) has announced that the National Medical Products Administration (NMPA)...
Roche’s Polivy Approved by China’s NMPA for Lymphoma Treatment
Swiss pharmaceutical giant Roche (SWX: ROG, OTCMKTS: RHHBY) has announced that the National Medical Products...
China Launches Eighth Round of National Volume-Based Procurement for 41 Drugs
The National Healthcare Security Administration has issued a notice to initiate the COVID-delayed eighth round...
Med Vision Secures A+ Round Financing to Accelerate Digital Therapy Commercialization
Hangzhou-based Med Vision Technology Co., Ltd. has successfully completed an A+ round financing, raising several...
MSD China to Take Legal Action Against Market Infringement of Molnupiravir
Merck Sharp & Dohme (MSD, NYSE: MRK)’s China unit has issued a WeChat notification vowing...